Navigation Links
InspireMD Reports Financial Results For Period Ended March 31, 2013
Date:5/8/2013

ore tax expenses (income)

(4,903)

(3,115)

(14,280)

(13,649)Tax Expenses (income)

(18)

25

31

7Net Loss$(4,885)

$(3,140)

$(14,311)

$(13,656)Net loss per share – basic and diluted

$(0.27)

$(0.18)

$(0.81)

$(0.82)Weighted average number of shares of common stock used in computing net loss per share – basic and diluted

18,196,083

17,044,737

17,662,175

16,596,379 CONSOLIDATED BALANCE SHEETS (2)
(U.S. dollars in thousands)ASSETSMarch 31,
2013June 30,
2012Current Assets:Cash and cash equivalents

$2,514

$10,284Restricted cash

91

37Accounts receivable:Trade

2,146

1,824Other

278

264Prepaid expenses

91

93Inventory:On hand

1,982

1,744On consignment63Total current assets7,102

14,309Property, plant and equipment, net of accumulated depreciation and amortization

467

462 

Other non-current assets:Deferred issuance costs

951

961Funds in respect of employee rights upon retirement

380

282Royalties buyout

897Total other non-current assets2,228

1,243Total assets$9,797

$16,014 LIABILITIES AND EQUITYMarch 31,
2013June 30,
2012Current liabilities:Accounts payable and accruals:Trade

$416

$441Other

2,885

2,925Advanced payment from customers

177

174Deferred revenues

10

10Convertible loan

7,385Total current liabilities10,873

3,550Long-term liabilities:Liability for employees rights upon retirement

495

354Convertible loan5,018Contingently redeemable warrants and others

1,832

1,706Total long-term liabilities2,327

7,078Total liabilities13,200
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
2. InspireMD Closes $25 Million Underwritten Public Offering
3. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
4. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
5. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
6. InspireMD Reports Results for Period Ended Dec. 31, 2012
7. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
8. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
9. InspireMD Reports Results For Period Ending Sept. 30, 2012
10. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
11. InspireMD to Present at Harvard Investors Group on June 27 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... British Columbia and MENLO PARK, Calif. ... (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol ... trial had been filed with the U.S. Food and Drug ... 50mg/m 2 has been opened at three clinical trial ... company also confirmed that gross proceeds of US$2.9 million have ...
(Date:8/19/2014)... August 19, 2014 According to ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... NAGOYA, Japan , Aug. 19, 2014 /PRNewswire/ ... and ASAHI INTECC (Securities Code 7747, Second Section, ... formalized plans to develop a new, differentiated fractional flow ... a device intended to improve handling compared to existing ... emerging field in interventional cardiology that exceeds $250 million ...
Breaking Medicine Technology:DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4
... 2010 Microfluidics International Corporation (OTC Bulletin Board: ... third quarter 2010 financial results on Tuesday, November 16, ... President and Chief Executive Officer, and Peter F. Byczko, ... host a conference call and live audio webcast. ...
... YORK, Nov. 9, 2010 Malaria No More and the ... NightWatch. Senegalese singer Youssou NDour and other international celebrities are ... celebrity voices and deliver an important nightly message about malaria. ... will use radio, television and cell phone text messaging (SMS) ...
Cached Medicine Technology:Microfluidics International Corporation to Report Third Quarter 2010 Financial Results on November 16, 2010 2World-Renowned Singer Youssou NDour Launches NightWatch Program 2
(Date:8/20/2014)... It’s no secret that millions of ... National Institute on Drug Abuse, nearly 24 million Americans ... more alarming is the fact that the total number ... Those locked in a struggle with substance abuse often ... now, the newly-redesigned AbuseTreatmentCenters.net has released updated lists of ...
(Date:8/20/2014)... The Institute for Integrative Nutrition ... to announce its new partnership with California ... university offering graduate programs featuring flexible learning. Graduates ... now eligible to receive six graduate credits towards ... , “I’m so thrilled to announce this new ...
(Date:8/20/2014)... Missouri federal judge has remanded a lawsuit filed by a ... NaturaLyte to the City of St. Louis Circuit Court, reports ... rejected an assertion by the defendants that the plaintiffs’ claims ... v. Fresenius Medical Care North America Inc., et al., No. ... of the dialysis products GranuFlo and NaturaLyte. In 2012, the ...
(Date:8/20/2014)... August 20, 2014 Botanica ... cell facial. Utilizing the new and popular stem ... targets fine lines and wrinkles and naturally repairs ... specials, highlighting the new service by offering clients ... the stem cell facial. , Pevonia® continues to ...
(Date:8/20/2014)... 2014 (HealthDay News) -- Taking the widely ... dying from heart-related causes, a new study suggests. ... the findings require urgent confirmation, said the Danish researchers ... risk is small and that guidelines for the use ... information is available. One heart expert wasn,t surprised ...
Breaking Medicine News(10 mins):Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 2Health News:Integrative Nutrition Announces New Partnership with California Institute of Integral Studies 3Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Antibiotic Might Raise Heart Risks for Some 2
... Senate Finance Committee handed a major victory to the health ... have created a "public option" to compete against private health ... health care system. The industry has fought the public option ... the year, fearing that the proposed policy would cut into ...
... RadioShack Corporation (NYSE: RSH ) will join seven-time ... Lance Armstrong Foundation) by participating for the first time ... RadioShack plans to activate almost 6,000 store locations to ... serves nationwide. RadioShack announced earlier this year its ...
... Anchor Bay Entertainment, the successful distributor of independent ... with Susan G. Komen for the Cure(®) in the ... months, Anchor Bay Entertainment will donate $1 for each ... well as develop specialized promotions for the campaign to ...
... problems later , WEDNESDAY, Sept. 30 (HealthDay News) -- New ... reduces the risk for neurological problems later. , Unfortunately, the ... disability. , Still, the findings, appearing in the Oct. 1 ... help fill a crucial gap in the effort to treat ...
... ORLANDO, Fla., Sept. 30 In light of recent flu ... University of Central Florida (UCF) athletes got protected against the ... UCF Arena, today. UCF students from men,s and women,s ... Athletic teams came out to set an example to the ...
... Incorporated (NYSE: HR ) announced it has entered into ... previous $400 million facility. The new facility includes 16 ... priced at 2.80% over LIBOR, with a 0.40% facility fee, ... loans of this nature. , Healthcare Realty Trust ...
Cached Medicine News:Health News:Insurance Industry Successful in Initial Fight Against Public Option; Public Feels Left Out 2Health News:Insurance Industry Successful in Initial Fight Against Public Option; Public Feels Left Out 3Health News:RadioShack Joins With Lance Armstrong to Raise Awareness for LIVESTRONG Day on Oct. 2 2Health News:RadioShack Joins With Lance Armstrong to Raise Awareness for LIVESTRONG Day on Oct. 2 3Health News:Anchor Bay Entertainment Joins Forces With Susan G. Komen for the Cure(R) in the Fight Against Breast Cancer 2Health News:Anchor Bay Entertainment Joins Forces With Susan G. Komen for the Cure(R) in the Fight Against Breast Cancer 3Health News:Cooling Helps Oxygen-Deprived Newborns 2Health News:Cooling Helps Oxygen-Deprived Newborns 3Health News:UCF Athletes Set Example While Getting Protected Against Flu 2Health News:Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility 2
... Clinical Xpert™ for PDAs is a new ... Clinical Xpert puts authoritative drug, disease and ... physicians and other prescribers, nurses, pharmacists, and ... decisions at the point of care, and ...
The 3-chip MediLive Trio Eye video camera is built to adapt to changing conditions during ophthalmic surgery with features designed for workflow optimization and maximum image quality....
... A valuable new tool for ... exhibits greater dynamic range and shows ... SWAP, at the same degree of ... has been shown to correlate with ...
... The VISUCAM non-mydriatic ... quality and simplicity of ... big enough to set ... photography, it features a ...
Medicine Products: